Latest filing published 19 Feb 2026 for Evolus, Inc..
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Albert G. White III discloses dealings in 2 companies, chiefly Cooper Companies, Inc. and Evolus, Inc. Between 8 January 2016 and 17 February 2026, the trades on record add up to 41 filings.
No open-market sale appears; the market trades are 4 purchases worth €1.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 23 share grants and 14 option exercises.
The median purchase comes to €416k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -12.6%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 19 February 2026, the filings show a share grant in Evolus, Inc. The latest purchase dates back some time: it was published 312 days ago, on 16 December 2025. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations